002349 精华制药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额96,831291,310358,390305,571328,218
投资活动产生之现金流量净额70,350(212,367)108,587(68,971)(123,408)
筹资活动产生之现金流量净额(89,498)(94,160)(182,046)(176,214)79,775
汇率变动对现金及现金等价物的影响1,3631,9974,097(1,117)(5,598)
现金及现金等价物净增加/(减少)79,046(13,220)289,02859,269278,987
期初现金及现金等价物余额914,199927,420638,391579,122300,135
期末现金及现金等价物余额993,245914,199927,420638,391579,122